Simon Bailey

This inventor holds 14 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Pfizer Corporation, California Institute of Technology, Holoclara, Inc.. Active years: 2002-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Simon Bailey. Retrieved from https://idiyas.com/inventor/simon-bailey

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14 (Patent Applications = 7)

% Patents Active = 57.1

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 3 (Patent Applications = 14)

Average Co-Inventor Count = 5.3

ph-index = 3

Forward Citations = 76(Granted Patents)

Location History:

Kent, GB (2002)
Sandwich, GB (2004)
La Jolla, CA (US) (2005 - 2006)
San Diego, CA (US) (2005 - 2024)

Company Filing History:

California Institute of Technology

where one patent can have more than one assignee

Years Active: 2002-2025

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12473323 - Ascaroside derivatives and methods of use (2025-11-18),

2. 11878968 - Aryl compounds and pharmaceutical compositions that modulate IKZF2 (2024-01-23),

3. 11845770 - Ascaroside derivatives and methods of use (2023-12-19),

4. 9133215 - Macrocyclic derivatives for the treatment of diseases (2015-09-15),

5. 8680111 - Macrocyclic derivatives for the treatment of diseases (2014-03-25),

6. 8119624 - Fused phenyl amido heterocyclic compounds (2012-02-21),

7. 7842713 - Fused phenyl amido heterocyclic compounds (2010-11-30),

8. 7470715 - Estrogen modulators (2008-12-30),

9. 7141586 - Nicotinamide derivatives useful as PDE4 inhibitors (2006-11-28),

10. 7060717 - Nicotinamide derivatives useful as PDE4 inhibitors (2006-06-13),

11. 6949573 - Nicotinamide derivatives useful as PDE4 inhibitors (2005-09-27),

12. 6897306 - 3-heterocyclylpropanohydroxamic acids (2005-05-24),

13. 6821972 - 3-heterocyclylpropanohydroxamic acid PCP inhibitors (2004-11-23),

14. 6448278 - Procollagen C-proteinase inhibitors (2002-09-10),

Title: The Innovative Contributions of Simon Bailey

Introduction

Simon Bailey is an accomplished inventor based in San Diego, California. With a remarkable portfolio of 13 patents, Bailey has made significant contributions to the field of pharmaceuticals and the treatment of immune disorders. His work continues to influence the development of innovative therapies.

Latest Patents

Bailey's recent patents showcase his expertise in modulating biological processes. One notable patent involves aryl compounds and pharmaceutical compositions that modulate IKZF2. This invention discloses compounds and salts that bind to and modulate cereblon activity, leading to the degradation of IKAROS family zinc finger proteins, such as IKZF2. Another significant patent focuses on ascaroside derivatives and their application in treating immune disorders and inflammation. The methods outlined in this patent detail ways to treat these conditions by administering specific compounds.

Career Highlights

Throughout his career, Simon Bailey has worked with prestigious organizations, including Pfizer Corporation and Pfizer Products Inc. His contributions in these settings have played a vital role in advancing research and development efforts in the pharmaceutical industry.

Collaborations

Bailey has collaborated with notable colleagues in his field, including Paul Vincent Fish and Kim James. These professional relationships have fostered an environment of innovation and have significantly contributed to his research endeavors.

Conclusion

In conclusion, Simon Bailey stands out as an influential inventor whose work has the potential to revolutionize treatments for immune disorders and inflammatory conditions. His dedication to innovation continues to inspire future advancements in the pharmaceutical sector.

Profile summary based on public USPTO records.